HOME
LUPIN FOUNDATION
CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information

SOUTH AFRICA

The South African region has shown remarkable growth in pharmaceutical sales over the years. This is primarily attributed to the Government’s initiatives to improve healthcare access for its citizens as well as a favourable economic outlook across the market. The pharmaceutical market is valued at USD 3.9 billion and growing at 8% in value terms.

In FY2019, Lupin’s South African subsidiary Pharma Dynamics (PD) achieved net revenues of ZAR 1,162 million. According to IQVIA Health, as of March 2019, PD showed a sales growth of 5%. In addition, it has maintained its ranking as the 4th largest generics player in the prescription generic market in South Africa.

While PD has entrenched its position as the largest pharmaceutical company in the Cardiovascular Systems (CVS) therapeutic market, it is also growing in the Central Nervous System (CNS) space. The CVS portfolio remains the largest part of its revenues, followed by the OTC portfolio.